Sign inJoin waitlistJoin the waitlist

Back to M D Anderson Cancer Center Hematology and Medical Oncology

Mir Lim

Hematology and Medical Oncology Fellow · University of Texas Health Science Center at Houston

Credentials: · ·

History

Hematology and Medical Oncology
University of Texas Health Science Center at Houston
2024–Present
Hematology and Medical Oncology Fellow
University of Texas Health Science Center at Houston
Present
Neurology
University of Texas Southwestern Medical Center
2021–2025
Internal Medicine
UTSW
2021–2024
Boston University School of Medicine
2017–2021

Research

Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma
JHEP Reports · 2023 · 61 citations
Liposomal Grb2 antisense oligodeoxynucleotide (BP1001) in patients with refractory or relapsed haematological malignancies: a single-centre, open-label, dose-escalation, phase 1/1b…
The Lancet Haematology · 2018 · 55 citations
Disease Etiology and Outcomes After Atezolizumab Plus Bevacizumab in Hepatocellular Carcinoma: Post-Hoc Analysis of IMbrave150
Gastroenterology · 2023 · 52 citations

Magdalena Espinoza
4 papers
Amit Singal
3 papers
Hao Zhu
3 papers
Joseph Franses
3 papers
Maishara Muquith
3 papers
BM
Bernadette Miramontes
2 papers · 2 as a resident
Elias Jabbour
2 papers
GB
Gautam Borthakur
2 papers
Guillermo Garcia-Manero
2 papers
Hagop Kantarjian
2 papers
Jorge Cortes
2 papers
Maro Ohanian
2 papers